Dengue Disease Surveillance: Improving Data for Dengue Control

PLoS Neglected Tropical Diseases

Volumn 8, Issue 11, 2014, Pages

  Horstick, Olaf ^a   Morrison, Amy C ^b,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Peru   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST OF ILLNESS; DENGUE; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; HUMAN; METHODOLOGY; NONHUMAN; PUBLIC HEALTH; SCIENTIFIC LITERATURE; SYSTEMATIC REVIEW (TOPIC);

EID: 84920432671     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003311     Document Type: Article

References (19)

1. WHO/TDR editor (2009) Dengue: guidelines for diagnosis, treatment, prevention and control. New edition. Geneva: WHO. 147 p.
2. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, et al. (2013) The global distribution and burden of dengue. Nature 496: 504–507.
3. Peeling RW, Artsob H, Pelegrino JL, Buchy P, Cardosa MJ, et al. (2010) Evaluation of diagnostic tests: dengue. Nat Rev Microbiol 8: S30–38.
4. Hunsperger EA, Yoksan S, Buchy P, Nguyen VC, Sekaran SD, et al. (2009) Evaluation of commercially available anti-dengue virus immunoglobulin M tests. Emerg Infect Dis 15: 436–440.
5. Blacksell SD, (2012) Commercial dengue rapid diagnostic tests for point-of-care application: recent evaluations and future needs? J Biomed Biotechnol 2012: 151967.
6. Horstick O, Farrar J, Lum L, Martinez E, San Martin JL, et al. (2012) Reviewing the development, evidence base, and application of the revised dengue case classification. Pathog Glob Health 106: 94–101.
7. WHO (2006) Scientific working group report on dengue. Geneva: WHO.
8. Edelman R, (2005) Dengue and dengue vaccines. J Infect Dis 191: 650–653.
9. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, et al. (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339: b2700.
10. Farrar J, Focks D, Gubler D, Barrera R, Guzman MG, et al. (2007) Towards a global dengue research agenda. Trop Med Int Health 12: 695–699.
11. Undurraga EA, Halasa YA, Shepard DS, (2013) Use of expansion factors to estimate the burden of dengue in Southeast Asia: a systematic analysis. PLoS Negl Trop Dis 7: e2056.
12. Brady OJ, Gething PW, Bhatt S, Messina JP, Brownstein JS, et al. (2012) Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis 6: e1760.
13. Brady OJ, Golding N, Pigott DM, Kraemer MU, Messina JP, et al. (2014) Global temperature constraints on Aedes aegypti and Ae. albopictus persistence and competence for dengue virus transmission. Parasit Vectors 7: 338.
14. Brady OJ, Johansson MA, Guerra CA, Bhatt S, Golding N, et al. (2013) Modelling adult Aedes aegypti and Aedes albopictus survival at different temperatures in laboratory and field settings. Parasit Vectors 6: 351.
15. Messina JP, Brady OJ, Scott TW, Zou C, Pigott DM, et al. (2014) Global spread of dengue virus types: mapping the 70 year history. Trends Microbiol 22: 138–146.
16. Horstick O, Runge-Ranzinger S, Nathan MB, Kroeger A, (2010) Dengue vector-control services: how do they work? A systematic literature review and country case studies. Trans R Soc Trop Med Hyg 104: 379–386.
17. Pilger D, Lenhart A, Manrique-Saide P, Siqueira JB, da Rocha WT, et al. (2011) Is routine dengue vector surveillance in central Brazil able to accurately monitor the Aedes aegypti population? Results from a pupal productivity survey. Trop Med Int Health 16: 1143–1150.
18. Runge-Ranzinger S, Horstick O, Marx M, Kroeger A, (2008) What does dengue disease surveillance contribute to predicting and detecting outbreaks and describing trends? Trop Med Int Health 13: 1022–1041.
19. Santamaria R, Martinez E, Kratochwill S, Soria C, Tan LH, et al. (2009) Comparison and critical appraisal of dengue clinical guidelines and their use in Asia and Latin America. Int Health 1: 133–140.